Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
PHIBRO ANIMAL HEALTH CORP (PAHC)
|
Add to portfolio |
|
|
|
| Price: |
$20.84
| | Metrics |
| OS: |
40.5
|
M
| |
14
|
% ROE
|
| Market cap: |
$844
|
M
| |
7
|
% ROIC
|
|
Net debt:
|
$398
|
M
| |
3.8
|
x Debt/EBITDA
|
|
EV:
|
$1.24
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
$105
|
M
| |
11.8
|
x EV/EBITDA
|
|
EBIT
|
$71.6
|
M
| |
17.3
|
x EV/EBIT
|
| EPS |
$0.89
| |
23.3
|
x P/E
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Jun-30-22 | Jun-30-21 | Jun-30-20 | Jun-30-19 | Jun-30-18 | Jun-30-17 | Jun-30-16 | Jun-30-15 |
| Revenues | 942.3 | 833.4 | 800.4 | 828.0 | 820.0 | 764.3 | 751.5 | 748.6 |
| Revenue growth | 13.1% | 4.1% | -3.3% | 1.0% | 7.3% | 1.7% | 0.4% | 8.2% |
| Cost of goods sold | 656.9 | 562.0 | 543.5 | 563.4 | 553.1 | 516.0 | 512.5 | 515.3 |
| Gross profit | 285.4 | 271.4 | 256.9 | 264.6 | 266.9 | 248.2 | 239.0 | 233.3 |
| Gross margin | 30.3% | 32.6% | 32.1% | 32.0% | 32.5% | 32.5% | 31.8% | 31.2% |
| Selling, general and administrative | 206.4 | 196.5 | 187.7 | 181.4 | 168.0 | 150.3 | 153.3 | 145.6 |
| EBITA | 87.9 | 83.6 | 78.1 | 89.3 | 104.8 | 103.9 | 91.3 | 92.2 |
| EBITA margin | 9.3% | 10.0% | 9.8% | 10.8% | 12.8% | 13.6% | 12.1% | 12.3% |
| Amortization of intangibles | 8.9 | 8.7 | 8.9 | 6.1 | 5.9 | 6.0 | 5.6 | 4.6 |
| EBIT | 79.0 | 74.9 | 69.2 | 83.2 | 98.9 | 97.9 | 85.7 | 87.7 |
| EBIT margin | 8.4% | 9.0% | 8.6% | 10.1% | 12.1% | 12.8% | 11.4% | 11.7% |
| Pre-tax income | 72.3 | 66.5 | 55.5 | 71.5 | 88.1 | 80.5 | 76.8 | 78.8 |
| Income taxes | 23.2 | 12.1 | 22.0 | 16.8 | 23.2 | 15.9 | -6.0 | 18.5 |
| Tax rate | 32.0% | 18.2% | 39.6% | 23.5% | 26.3% | 19.8% | | 23.5% |
| Net income | 49.2 | 54.4 | 33.6 | 54.7 | 64.9 | 64.6 | 82.7 | 60.3 |
| Net margin | 5.2% | 6.5% | 4.2% | 6.6% | 7.9% | 8.5% | 11.0% | 8.1% |
| |
| Diluted EPS | $1.21 | $1.34 | $0.83 | $1.35 | $1.61 | $1.61 | $2.07 | $1.51 |
| Shares outstanding (diluted) | 40.5 | 40.5 | 40.5 | 40.5 | 40.4 | 40.0 | 40.0 | 39.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|